. Cloning and characterization of mouse 5Ј-AMP-activated protein kinase ␥3 subunit. Am J Physiol Cell Physiol 286: C283-C292, 2004. First published September 24, 2003 10.1152/ajpcell.00319.2003.-Naturally occurring mutations in the regulatory ␥-subunit of 5Ј-AMP-activated protein kinase (AMPK) can result in pronounced pathological changes that may stem from increases in muscle glycogen levels, making it critical to understand the role(s) of the ␥-subunit in AMPK function. In this study we cloned the mouse AMPK␥3 subunit and revealed that there are two transcription start sites, which result in a long form, ␥3L (AF525500) and a short form, ␥3S (AF525501). AMPK␥3L is the predominant form in mouse and is specifically expressed in mouse skeletal muscle at the protein level. In skeletal muscle, AMPK␥3 shows higher levels of expression in fast-twitch white glycolytic muscle (type IIb) compared with fast-twitch red oxidative glycolytic muscle (type IIa), whereas ␥3 is undetectable in soleus muscle, a slow-twitch oxidative muscle with predominantly type I fibers. AMPK␥3 can coimmunoprecipititate with both ␣ and ␤ AMPK subunits. Overexpression of ␥3S and ␥3L in mouse tibialis anterior muscle in vivo has no effect on ␣1 and ␣2 subunit expression and does not alter AMPK␣2 catalytic activity. However, ␥3S and ␥3L overexpression significantly increases AMPK␣1 phosphorylation and activity by ϳ50%. The increase in AMPK␣1 activity is not associated with alterations in glycogen accumulation or glycogen synthase expression. In conclusion, the ␥3 subunit of AMPK is highly expressed in fast-twitch glycolytic skeletal muscle, and wild-type ␥3 functions in the regulation of ␣1 catalytic activity, but it is not associated with changes in muscle glycogen concentrations.
adenosine 5Ј-monophosphate-activated protein kinase; AMPK␥3 short form; AMPK␥3 long form; cystathionine ␤-synthase domain THE 5Ј-AMP-ACTIVATED PROTEIN KINASE (AMPK) functions as a critical sensor of cellular energy charge in a wide range of tissues and cells. AMPK is activated in response to stimuli that decrease ATP and phosphocreatine concentrations (11, 23, 38) by both allosteric and phosphorylation-dependent mechanisms (13, 15, 24, 41) . In mammals as well as yeast, AMPK has been proposed to regulate a host of metabolic and transcriptional events, such as glucose transport (21, 26, 30, 46) , fatty acid oxidation (16, 37, 42, 48) , leptin regulation of lipid metabolism (32) , and gene transcription (29, 51) . AMPK is a heterotrimer, consisting of one catalytic subunit (␣) and two noncatalytic and presumably regulatory subunits (␤, ␥) (33, 40) . Each of the subunits has multiple isoforms, and various configurations of the heterotrimer have been reported, including ␣1␤1␥1, ␣1␤2␥1, ␣2␤1␥1, and ␣2␤2␥1 (10, 44) .
Although the two ␣ catalytic subunit isoforms of AMPK have been the major focus of AMPK research over the last 10 years, there is now increasing interest in understanding the roles of the ␤-and ␥-subunits in AMPK function. Three ␥-isoforms have been identified, ␥1, ␥2, and ␥3. Northern blot analysis of human tissues reveals that ␥1 is widely distributed, whereas AMPK␥2 is also widely distributed but has very high expression levels in heart (11, 31) . Interestingly, ␥3 is almost exclusively expressed in the skeletal muscle of humans (11, 31) . The divergent expression patterns of the ␥ isoforms among tissues suggest that the different isoforms have tissue-specific functions (11, 44) . In comparing the human ␥1, ␥2, and ␥3 amino acid sequences, the NH 2 termini have significant variations in length and identity, suggesting that this region may play an important role in conferring isoform specificity either by targeting different downstream molecules or by responding to different upstream stimuli. However, specific functions of the NH 2 -terminal region have not been identified for all three ␥-subunits, and there are no known protein motifs in this region. In contrast, the COOH-terminal region contains four consecutive cystathionine ␤-synthase (CBS) domains that are highly conserved in all ␥ isoforms (11, 41) . These CBS domains occupy approximately half of the ␥-subunit, suggesting that these domains are also critical for ␥-subunit function (7) . Indeed, mutations of CBS domains in a number of proteins, including the CBS domains of the ␥-subunit of AMPK, are associated with various disease states (4, 8, 20, 28, 31) . In skeletal muscle and heart, mutations of the CBS domains in ␥2 and ␥3 have been shown to be associated with alterations in glycogen metabolism (3, 4, 12, 31) .
In recent years, skeletal muscle has become a major focus of the AMPK field because AMPK may be involved in the regulation of glucose uptake, glycogen metabolism, fatty acid oxidation, and gene transcription in this tissue (5, 21, 23, 25, 34, 36, 43, 47, 49) . Although mutations in ␥-subunit CBS domains, including ␥3, lead to pathological conditions, very little is known about the mechanisms by which the ␥-isoforms may regulate AMPK activity, cellular metabolism, and tissue phenotype. There have been discrepancies in reports of tissue distributions of ␥3 mRNA and protein (11, 31) , as well as conflicting reports of the translation initiation sites of the human AMPK␥3 gene (11, 31) . In this study we have cloned the full-length mouse AMPK␥3 gene and, by determining its translation initiation sites, have revealed that there are two splice variants of ␥3. We have also characterized the AMPK␥3 isoforms and investigated the effects of overexpressing the wild-type AMPK␥3 subunit in vivo on AMPK activity and glycogen metabolism in skeletal muscle.
METHODS

Materials. [␥-
32 P]ATP was obtained from Perkin-Elmer. Affinity purified polyclonal antibody against AMPK␥3 was raised against mouse AMPK␥3 peptide NH 2-CLVDETQHLLGV-COOH (␥3L; 457-467), which is also conserved in mouse ␥3S, human ␥3, and pig ␥3. Polyclonal antibodies against AMPK␣1 and AMPK␣2 were produced against the peptide sequence 339-358 of AMPK␣1 and 352-366 of AMPK␣2 (35) ; anti-AMPK␣1/2 antibody was raised against the peptide sequence 2-16 of AMPK␣1/2 (AEKQKH-DGRVKIGHY), which is conserved in AMPK␣1 and AMPK␣2 isoforms. Anti-phospho-AMPK␣ antibody was from Cell Signaling Technology; anti-glycogen synthase antibody was provided by Dr. John C. Lawrence, Jr. (University of Virginia, Charlottesville, VA); anti-phospho-glycogen synthase antibody was from Oncogene Research Products; the pCAGGS vector was a gift from Dr. J. Miyazaki (Osaka University, Osaka, Japan); and pMT-AMPK␤1 vector and anti-AMPK␥1 antibody were provided by Dr. Lee A. Witters (Dartmouth Medical School, Hanover, NH).
Animals. Female (8 wk) ICR mice (30 g) were purchased from Taconic. Protocols for animal use were reviewed and approved by the Institutional Animal Care and Use Committee of the Joslin Diabetes Center and were in accordance with National Institutes of Health guidelines.
Human muscle. The experiment using a human muscle lysate study with human subjects was approved by the Ethical Committee at the Karolinska (35) .
Cloning of mouse AMPK␥3 cDNA. Total RNA was extracted from 100 mg of mouse skeletal muscle using Tri Reagent (Molecular Research Center). Total RNA (5 g) was subjected to the oligo(dT) primer reverse transcription (RT) reaction (Invitrogen), and the cDNA products were used as a source for polymerase chain reaction (PCR) templates. The primers were designed on the basis of conserved regions of pig and human AMPK␥3: sense, 5Ј-tgctgagtccaccggg-3Ј; and antisense, 5Ј-agcagggctgagcacc-3Ј. The PCR product was subcloned into pCR 2.1-TOPO vector (Invitrogen) and sequenced. To obtain the upstream extension of 5Ј-end and the downstream extension of 3Ј-end of RT-PCR product, 5Ј-and 3Ј-rapid amplification of cDNA ends (RACE) was performed using a Marathon-Ready cDNA kit (Clontech). The antisense primer for 5Ј-RACE, 5Ј-agccatggcatcataacaggtgtgttcc-3Ј, and sense primer for 3Ј-RACE, 5Ј-tctggagggagttctctcctgccagc-3Ј, were designed on the basis of the DNA sequence of RT-PCR product as described above. 5Ј-RACE was performed between the anchor sense primer AP1 (Clontech) and the 5Ј-RACE antisense primer. The resulting PCR products were reamplified by using the nested sense primer AP2 (Clontech) and the same reverse primer, and the PCR products were cloned into pCR 2.1-TOPO vector for cloning and sequencing. 3Ј-RACE was performed between the 3Ј-RACE sense primer and anchor antisense primer AP1, and the resulting PCR products were reamplified by using the same sense primer and nested antisense primer AP2. The PCR products were also cloned into pCR 2.1-TOPO vector and further sequenced.
Cloning of mouse genomic AMPK␥3. An AMPK␥3L cDNA fragment (246-822) was used as a probe to screen the mouse genomic DNA library (IncyteGenomics). The ␥3-containing clones were confirmed by Southern Blotting using the same probe. The genomic organization was identified by comparing cDNA and genomic sequences.
Muscle processing. Muscles were dissected and snap frozen in liquid nitrogen. The pulverized samples were weighed and Polytron homogenized (Brinkmann Instruments) in ice-cold lysis buffer (1:10, wt/vol) containing 20 mM Tris⅐HCl (pH 7.4), 1% Triton-X 100, 50 mM NaCl, 250 mM sucrose, 50 mM NaF, 5 mM sodium pyrophosphate, 2 mM dithiothreitol (DTT), 4 mg/l leupeptin, 50 mg/l trypsin inhibitor, 0.1 mM benzamidine, and 0.5 mM PMSF, followed by centrifuging at 14,000 g for 20 min at 4°C. Supernatants were removed and used for protein concentration measurements, Western blotting, and AMPK activity assay.
Cell culture. L6 myoblast cells (1 ϫ 10 6 cells; gift from Dr. Amira Klip, University of Toronto, Toronto, ON, Canada) were plated on 60-mm dishes and grown in ␣-MEM with 10% fetal bovine serum. Each plasmid DNA (7 g) was introduced into cells with Lipofectamine 2000 reagent (Invitrogen). Cells were then cultured for another 48 h and then harvested with ice-cold AMPK lysis buffer.
Immunoblotting. Protein (20 g) from cells and muscle lysates was separated by 8% SDS-PAGE and transferred to nitrocellulose membranes. The membranes were blocked in Tris-buffered saline with 0.05% Tween 20 (TBST) and 5% nonfat milk for 1 h at room temperature. The membranes were incubated overnight at 4°C with the appropriate primary antibodies. Bound primary antibodies were detected with anti-rabbit (Amersham) or mouse immunoglobulinhorseradish peroxidase-linked whole antibody (Transduction Laboratories, Lexington, KY). The membranes were washed with TBST and then incubated with enhanced chemiluminescence reagents (PerkinElmer) and exposed to film. Bands were visualized and quantified using Image-Quant software (Molecular Dynamics).
mRNA levels of AMPK␥3L and AMPK␥3S. The mRNA levels were determined on the basis of PCR. cDNA was synthesized from mouse quadriceps muscle mRNA by reverse transcription, adaptor-ligated double-strand cDNA was used as a template (Clontech), and the adaptor sequence (5Ј-ccatcctaatacgactcactatagggc-3Ј) attached to the 5Ј-end of cDNA including both ␥3S and ␥3L cDNA was used as the sense primer. The sequence 5Ј-agccatggcatcataacaggtgtgttcc-3Ј, conserved in both ␥3L and ␥3S, was used as the antisense primer. The two resulting products from the unsaturated PCR reaction were separated by 1% agarose gel and confirmed by DNA sequencing.
Immunoprecipitation. Muscle lysates (200 g) were incubated with anti-AMPK␣1/2 or -AMPK␤ antibody-bound protein A/G beads (Santa Cruz Biotechnology, Santa Cruz, CA) overnight at 4°C. The immunocomplex was washed with lysis buffer and boiled in Laemmli's buffer. The samples were separated by 8% SDS-PAGE, transferred to nitrocellulose membranes, and then immunoblotted with appropriate antibodies.
AMPK activity assay and glycogen content. AMPK activity assay was performed as described by Musi et al. (35) . Briefly, muscle lysates were immunoprecipitated with specific antibodies to the ␣1 and ␣2 catalytic subunits of AMPK and protein A/G beads. Immunoprecipitates were assayed for AMPK activity in assay buffer containing 0.2 mM AMP, 0.2 mM ATP (2 Ci [␥-32 P]ATP), and 0.2 mM synthetic AMPK substrate peptide (SAMS) with the sequence HMRSAMSGLHLVKRR for 20 min at 30°C (14, 35) . For glycogen measurements, a muscle piece was weighed and hydrolyzed in 2 N HCl at 100°C for 2 h, followed by neutralization with 2 N NaOH. Glycogen concentrations were then determined by the hexokinase enzymatic method, using the glucose HK reagent (Sigma, St. Louis, MO).
Generation of recombinant AMPK␥3. The coding region of AMPK␥3S or AMPK␥3L was obtained by PCR with the sense primer spanning the start codon containing a Kozac sequence, with or without a Flag-tag sequence and antisense primer spanning the stop codon. The purified PCR product was subcloned into pCR 2.1-TOPO vector and sequenced. The EcoI fragment containing the AMPK␥3 in the pCR 2.1-TOPO vector was excised and subcloned into the pCAGGS vector. Sense primers were as follows: ␥3S, 5Ј-gcggccgcgccaccatggacttcttagaacaaggagaaaactcatggc-3Ј; Flag-␥3S, 5Ј-gcggccgcgccaccatggactacaaggacgacgatgacaagatggacttcttagaacaaggagaaaactcatggc-3Ј; ␥3L, 5Ј-gcggccgcgccaccatggagcccgagctggagcacac-3Ј; and Flag-␥3L, gcggccgcgccaccatggactacaaggacgacgatgacaagatggagcccgagctggagcacac-3Ј; and the antisense primer for ␥3S, Flag-␥3S, ␥3L, and Flag-␥3L was 5Ј-gaggccgctcaggcgctgagggcatcga-3Ј.
Expression of AMPK␥3S and AMPK␥3L in tibialis anterior mus-
cle. DNA injection and in vivo electroporation were done by a modification (18) of the method of Aihara and Miyazaki (2) . Mice were anesthetized with pentobarbital sodium (90 mg/kg body wt ip), and 100 g of pCAGGS-AMPK␥3S, pCAGGS-AMPK␥3L, or an equal amount of empty pCAGGS vector in 25 l of saline was injected into the tibialis anterior (TA) muscle, using an insulin syringe with a 29-gauge needle. For the control, an equal amount of pCAGGS alone was injected into the opposite leg. With the use of an electric pulse generator, square-wave electrical pulses (200 V/cm) were applied eight times at a rate of 1 pulse/s with each pulse being 20 ms in duration. The electrodes used were a pair of stainless steel needles inserted and fixed 5 mm apart into the TA muscle. Nine days after gene delivery, the muscles were removed and prepared for AMPK activity, Western blotting, and the measurements of glycogen content.
Muscle contraction. pCAGGS-AMPK␥3S, pCAGGS-AMPK␥3L, or an equal amount of empty pCAGGS vector was injected into the TA muscle, followed by electroporation. Nine days later, mice were anesthetized with pentobarbital sodium (90 mg/kg body wt ip), the sciatic nerves of both legs were surgically exposed, and subminiature electrodes were attached to the nerves (22, 39) . Hindlimb muscles of one leg were electrically stimulated to contract for 20 min (train rate 1/s, train duration 500 ms, rate 100 pulses/s, duration 0.1 ms, 1-3 V), using a Grass S88 pulse generator, and the other leg served as a sham-operated control. Immediately after nerve stimulation, mice were killed and tibialis muscles were rapidly dissected and frozen in liquid nitrogen.
Statistical analysis. Data are presented as means Ϯ SE. One-way analysis of variance was used for statistical evaluation. Differences between means were determined using the Student-Newman-Keuls test.
RESULTS
Cloning mouse AMPK␥3 gene. The full-length sequence of the mouse AMPK␥3 gene was obtained by a combination of RT-PCR and 5Ј-and 3Ј-RACE. Sequence analysis of the 1,197-bp fragment from RT-PCR revealed a sequence similar to human and pig AMPK␥3 that was used to design primers for both 5Ј-and 3Ј-RACE. The 3Ј-RACE products were 1,500 bp; sequencing and contiguous analysis revealed that they overlapped with the RT-PCR core 1,197-bp fragment. This demonstrated that the fragment from 3Ј-RACE is an extension of the core fragment of the mouse AMPK␥3 gene. The 5Ј-RACE product contained 600-and 630-bp bands. Sequencing and contiguous analysis revealed that the two fragments shared the same sequence at their 3Ј-region and that this region also overlapped with the core 1,197-bp fragment of mouse AMPK␥3 gene, with the remaining 5Ј-regions being different (Fig. 1B) . The RT-PCR and 3Ј-and 5Ј-RACE results suggest that there are two variants of the mouse AMPK␥3 gene that have distinct 5Ј-regions but are identical throughout the remainder of the gene. Sequence analysis showed that variant 1 contains a 1,392-bp open reading frame. The initiation methionine in variant 1 was designed by an upstream in-frame stop codon and the Kozac sequence surrounding it, and no obvious poly(A) tail or polyadenylation site consensus sequence was found in the 3Ј-noncoding region. The sequence analysis of variant 2 showed that it contains a 1,467-bp open reading frame (Fig. 1B) and shared the same 3Ј-noncoding region with variant 1. The first methionine in variant 2 was identified by the preceding stop codon (Fig. 1B) . Genomic DNA analysis demonstrated that the two variants are the result of different splicing of the first exon (Fig. 1B) . On the basis of the length of the open reading frame, we named variants 1 and 2 the AMPK␥3 short form (AMPK␥3S; AF525501) and the AMPK␥3 long form (AMPK␥3L; AF525500), respectively. The Mouse Genome Informatics ID for both ␥3S and ␥3L is MGI:1891343. ␥3S contains 465 deduced amino acids, whereas ␥3L contains 490 amino acids. The two splice isoforms share 100% identity except for an extra 25 amino acids at the NH 2 -terminal of ␥3L (Fig. 1B) . Both AMPK␥3S and AMPK␥3L share high identity and similar overall protein structure with pig and human AMPK␥3 subunits, and little identity with the ␥1 and ␥2 subunits. Figure 1C shows the deduced amino acid sequence alignment of mouse ␥3S and ␥3L compared with pig ␥3, the two different human ␥3 sequences that were reported with different initiation sites, and rat ␥3 (XM_237293). Mouse ␥3S shows overall 85.5% identity to human (AF214519) and pig ␥3. Mouse ␥3L is most similar to another reported human ␥3 gene (NM_017431) that contains an altered initiation site and also has 85.5% identity. The four CBS domains are highly conserved, showing 96% identity in all species, whereas the remainder of the NH 2 -terminal region shows 66% identity. Interestingly, both AMPK␥3 splice variants are rich in serine and threonine at the NH 2 -terminal region; these are potential phosphorylation sites for a number of protein kinases including glycogen synthase kinase 3, protein kinase A, and protein kinase C, based on consensus sequence searches for these kinases using PhosphoBase (http://www.cbs.dtu.dk/databases/ PhosphoBase/).
AMPK␥3 protein expression. To determine the expression pattern of AMPK␥3, we generated an antibody against a conserved sequence within COOH termini of mouse ␥3S and ␥3L, human ␥3, and pig ␥3 (Fig. 1C) . Immunoblotting with ␥3 antibody revealed that AMPK␥3 is highly expressed in gastrocnemius muscle, with no detectable signal in heart, brain, lung, liver, kidney, pancreas, spleen, white fat, or brown fat ( Fig. 2A) . These results are consistent with Northern hybridization data from human tissues, which showed that AMPK␥3 is specifically expressed in skeletal muscle (11, 31) . Interestingly, white fast-twitch glycolytic skeletal muscle that contains mostly type IIb fibers (white quadriceps and white gastrocnemius) showed higher levels of AMPK␥3 expression compared with the red fast-twitch oxidative-glycolytic muscle, which contains primarily type IIa fibers (red quadriceps and red gastrocnemius). AMPK␥3 was not detectable in soleus, a muscle that is composed almost exclusively of red slow-twitch oxidative type I fibers. This expression pattern suggests that AMPK␥3 plays a unique role in skeletal muscle, especially in the more fast-twitch glycolytic fiber types.
Immunoblotting of mouse skeletal muscle (quadriceps) and human skeletal muscle with ␥3 antibody reveals a single band (Fig. 2B) . To determine whether ␥3S or ␥3L is expressed in mouse and human skeletal muscle, we overexpressed recombinant mouse ␥3S and ␥3L in L6 myoblast cells that do not express endogenous AMPK␥3. Cell lysates were compared with endogenous ␥3 from mouse and human muscle lysates. As shown in Fig. 2B , mouse endogenous AMPK␥3 had the same molecular size as ␥3L, suggesting that AMPK␥3L is the predominant form in mouse muscle. On the other hand, human AMPK␥3 had the same molecular size as ␥3S, although this finding will need to be confirmed in future studies using overexpressed human ␥3. The double band on SDS-PAGE of overexpressed ␥3S suggests that the expressed protein in the cells was partially degraded.
In addition, ␥3L is more abundant compared with ␥3S at the mRNA level (Fig. 2C) , and this is consistent with Western blotting data showing that ␥3L is the predominant form in skeletal muscle (Fig. 2B) . The ␥3S variant was detected by PCR (5Ј-RACE), but protein was not expressed. This may be explained by the following possibilities: 1) the lower ␥3S mRNA results in very low levels of ␥3S protein, beyond the detection of the ␥3 antibody; 2) there may be an inhibitory mechanism at the translational or posttranslational steps that suppresses ␥3S protein expression; and/or 3) ␥3S protein is less stable and is more rapidly degraded.
The molecular masses of ␥3S and ␥3L in SDS-PAGE were 64 and 67 kDa, respectively, different from their predicted molecular masses of 51 and 54 kDa. The reason for the mobility shift of ␥3 in a denatured gel is unclear, although interestingly, the same phenomenon has been observed in the AMPK␤1 subunit. In SDS-PAGE the molecular mass of AMPK␤1 isolated from rat liver is 38 kDa higher than the predicted molecular mass of 30 kDa (50) .
Association of ␥3 subunit with ␣-and ␤-subunits. To determine whether the ␥3 subunit associates with the ␣ catalytic subunit, we used mouse muscle lysates for the immunoprecipitation of AMPK␣, using an anti-AMPK␣-specific antibody that recognizes both ␣1 and ␣2. As shown in Fig. 3A , the anti-AMPK␣1/2 antibody immunoprecipitates ␣1/2 and coprecipitates both the ␤1 subunit and the ␥3 subunit from mouse skeletal muscle lysates. There was also concomitant immunodepletion of AMPK␣1/2, AMPK␤1, and the AMPK␥3 subunits from the immunosupernatant. In contrast, control IgG did not pull down any of these proteins, and AMPK␣1/2, AMPK␤1, and AMPK␥3 are preserved in the supernatant. This experiment also confirms that AMPK␥3 runs as a 67-kDa band in SDS-PAGE (Fig. 2, A and B, and Fig. 3A) . When AMPK␤1 was immunoprecipitated in skeletal muscle lysates with the use of a commercially available antibody, AMPK␤1 was barely detectable (not shown), and because an antibody for the immunoprecipitation of AMPK␤2 was not commercially available, the potential association of ␤ with ␥3 was determined by expressing exogenous AMPK␤1 and ␥3L in L6 myoblast cells. We chose ␥3L because this is the endogenous splice isoform of Fig. 1 . A: nucleotide sequence and the deduced amino acid sequence of AMP-activated protein kinase (AMPK) ␥3S. Nucleotides and amino acids are numbered on the left and right, respectively. The translation initiation codon is used as the starting nucleotides for numbering. The in-frame translation termination codon is marked by an asterisk. B: AMPK␥3S and AMPK␥3L are different splice isoforms. Top: representation of AMPK␥3S; the translation initiation codon is located at exon III. Bottom: representation of AMPK␥3L; the translation initiation codon is localized in exon I. The nucleotide sequence and the deduced amino acid sequence specific for AMPK␥3L are shown in boxes. The intron boundaries between exons I and II are indicated in parenthesis. The in-frame stop codon is indicated by an asterisk. C: comparison of the mouse AMPK␥3 amino acid sequence with human, pig, and rat sequences. Alignment was performed between amino acid sequences of mouse ␥3S (M␥3S; AF525501), mouse ␥3L (M␥3L; AF525500), human ␥3 (H␥3; AJ249977 and AF214519), pig ␥3 (P␥3; AF214520), and rat ␥3 (R␥3; XM_237293). AMPK␥3S amino acid sequence was used as a master sequence. Dash indicates identity to the master sequence; dot indicates alignment gaps. Cystathionine ␤-synthase (CBS) domain sequences are boxed, and the peptide sequence (␥3L 457-467) in bold letters was used to generate the AMPK␥3 antibody. Fig. 2 . A: distribution of AMPK␥3 in different mouse tissues. Protein (20 g) from different mouse tissue lysates was separated by 8% SDS-PAGE and transferred to a nitrocellulose membrane. AMPK␥3 was detected by immunoblotting with an anti-AMPK␥3-specific antibody. B: AMPK␥3 splice isoforms in mouse and human skeletal muscles. Mouse and human skeletal muscle lysates with endogenous AMPK␥3 and cell lysates of L6 myoblasts with overexpressed (OE) AMPK␥3L and AMPK␥3S were separated by 8% SDS-PAGE and immunoblotted with an anti-AMPK␥3 antibody. C: comparison of the mRNA levels of ␥3L and ␥3S in mouse skeletal muscle. PCR products from sense adaptor primer attached to double-strand cDNA including both ␥3L and ␥3S and an antisense primer conserved in both ␥3L and ␥3S (see METHODS) were separated by 1% agarose gel. DNA sequence analysis demonstrated that the top band is from ␥3S and the bottom band is from ␥3L. Because the 5Ј-noncoding region plus coding region of ␥3S PCR product is longer than that of ␥3L, ␥3S migrates more slowly through the gel. AMPK␥3 in mouse skeletal muscle. This experiment revealed that expressed AMPK␥3 could be coimmunoprecipitated with the ␤1 subunit (Fig. 3B) .
Overexpression of AMPK␥3S and AMPK␥3L in mouse TA muscle in vivo. To determine the effects of ␥3S and ␥3L on AMPK activity and glycogen metabolism in skeletal muscle, we used a gene transfer/electroporation system to express the two splice variants in mouse TA muscle in vivo. By using this method in preliminary experiments using the LacZ gene, 85.7 Ϯ 2.3% (n ϭ 6) of fibers were determined to express ␤-galactosidase (18) . AMPK␥3S and AMPK␥3L expression levels were measured at days 7, 9, and 14 after gene transfer/ electroporation, and maximal expression occurred at day 9 (ϳ1.5-to 2.5-fold greater than endogenous AMPK␥3); thus all subsequent experiments were done using this time point. Figure 4A , top, shows that, as predicted, Flag-tagged AMPK␥3L ran at a higher molecular mass compared with Flag-tagged ␥3S. Figure 4A , middle, shows the degree of overexpression of ␥3S and ␥3L compared with endogenous ␥3 and also confirms the experimental results shown in Fig. 2B , demonstrating that the ␥3L splice variant is endogenously expressed in mouse skeletal muscle. Figure 4A , bottom, shows that recombinant AMPK ␥3S and AMPK␥3L did not affect endogenous ␥1 protein levels, suggesting that ␥3 overexpression does not replace this isoform. Endogenous ␥2 isoform was not determined because anti-␥2 antibodies were not commercially available. In lysates from TA muscle, overexpressed AMPK␥3S and AMPK␥3L could be coimmunoprecipitated with the ␣-subunit (Fig. 4B) .
Overexpression of both AMPK␥3S and AMPK␥3L in vivo resulted in a significant increase in AMPK␣1 catalytic activity (Fig. 5A, left) . The increase in AMPK␣1 activity was associated with an increase in AMPK␣1 Thr 172 phosphorylation, determined by AMPK␣1 immunoprecipitation followed by Western blotting using a phosphospecific AMPK␣ antibody (Fig. 5A, right) . The increases in AMPK␣1 activity and phosphorylation were not due to an increase in AMPK␣1 protein expression (Fig. 5A, right) . In contrast, AMPK␥3S and AMPK␥3L expression in vivo had no effect on AMPK␣2 activity, phosphorylation, and expression (Fig. 5B) , although the phosphorylation of AMPK␣2 in the basal condition was barely detectable. The increase in AMPK␣1 activity was not associated with changes in glycogen concentrations in the muscle (Fig. 5C ). Consistent with this finding, overexpression of AMPK␥3S and AMPK␥3L had no effect on glycogen synthase protein expression or the phosphorylation state of glycogen synthase (Fig. 5C ). Several other muscle proteins were also not altered by expression of AMPK␥3S and AMPK␥3L, including GLUT-4, citrate synthase, and phosphoacetyl CoA carboxylase proteins known to be involved in the regulation of glucose uptake, mitochondria biogenesis, and fatty acid oxidation, respectively (data not shown).
In addition, AMPK␥3L or AMPK␥3S overexpression did not change the susceptibility of AMPK to activation by con- Fig. 3 . A: association of AMPK␣1/2 with AMPK␤1 and AMPK␥3 subunits. An antibody produced against a homologous region of the NH2-terminal of AMPK␣1 and AMPK␣2 was used to immunoprecipitate (IP) both AMPK␣1 and AMPK␣2 from mouse muscle lysates. The immunoprecipitates and the supernatants were subjected to SDS-PAGE. An unrelated IgG was used as a control. The membranes were immunoblotted with anti-AMPK␣1/2, anti-AMPK␥3 antibody, or anti-AMPK␤1 antibodies. B: association of overexpressed AMPK␤1 with AMPK␥3. Flag-tagged AMPK␥3L, HA-tagged AMPK␤1, or empty vector were transfected to L6 myoblast cells, and cells were harvested 2 days later. Cell lysates were immunoprecipitated with anti-AMPK␤1 antibody, and immunoprecipitates were immunoblotted with anti-HA (AMPK␤1) or anti-Flag (AMPK␥3) antibodies. Fig. 4 . Overexpression of ␥3S and ␥3L in tibialis anterior (TA) muscle. Flag-tagged AMPK␥3S-pCAGGS, AMPK␥3L-pCAGGS, or empty vector (V) was injected into mouse TA muscle, followed by electroporation. Nine days later, TA muscles were dissected and processed as described in METHODS. A: muscle lysates were separated by SDS-PAGE and then immunoblotted with anti-Flag (top), anti-AMPK␥3 (middle), and anti-AMPK␥1 (bottom) antibodies. B: anti-AMPK␣1/2 antibody was used for immunoprecipitation, and immunoprecipitates were immunoblotted with anti-AMPK␣1/2 and anti-Flag (AMPK␥3) antibodies.
traction. As we and others have previously reported (19, 46) , in situ contraction resulted in a very modest increase in AMPK␣1 activity, and this increase was not different among the three groups (vector control: 33.4 Ϯ 14.8% over basal, ␥3S: 27.6 Ϯ 14.8%, ␥3L: 26.7 Ϯ 13.4%, n ϭ 8/group). The increase in AMPK␣2 activity in response to in situ contraction was also similar among the three groups (vector control: 116.7 Ϯ 14.5%, ␥3S: 90.3 Ϯ 23.5%, ␥3L: 121.8 Ϯ 26.5%, n ϭ 8/group). ␥3L and ␥3S expression was confirmed by Western blotting of muscle lysates.
DISCUSSION
We cloned the mouse AMPK␥3 gene and determined that there are two translation initiation sites that lead to two different AMPK␥3 splice isoforms, a short form, ␥3S, and a long form, ␥3L (Fig. 1, A-C) . Both ␥3L and ␥3S are full-length genes (Fig. 1B) and, by genomic DNA analysis, are identified as two splice isoforms (Fig. 1B) . Western blot analysis of mouse and human muscle lysates suggests that ␥3L is the predominant form in mouse skeletal muscle (Fig. 2B) , whereas ␥3S is probably the predominant form in human skeletal muscle (Fig. 5) . The finding suggests that both splice variants are physiologically relevant. This finding also clarifies discrepancies in previous reports showing differences in translation initiation sites for the human ␥3 gene (11, 31) . By immunoprecipitation with anti-␣-and ␤-subunit antibodies, our data also show that the ␥3 subunit is associated with the ␣-and ␤-subunits (Fig. 3, A and B) . Thus the ␥3 subunit can be a component of the AMPK heterotrimeric complexes, similar to what has been demonstrated for the ␥1 subunit (50) and the yeast isoform of the ␥-subunit, SNF4 (9) .
Western blot analysis of mouse tissue lysates using a ␥3-specific antibody clearly showed that AMPK␥3 was only detected in skeletal muscle. However, another report has suggested that ␥3 is mainly distributed in brain and testis, by measuring the proportion of total AMPK activity (11) . Although we do not have an explanation for the difference between our work and that of Cheung et al. (11) , our data are consistent with Northern blotting results from two independent groups showing ␥3 mRNA only in skeletal muscle (11, 31) . Though ␥3 is only present in skeletal muscle, we found different levels of expression of ␥3 in muscle composed of various muscle fiber types. White muscles, which contain predominantly fast-twitch glycolytic (type IIb) fibers, showed the highest levels of ␥3 expression. The red muscles, which contain predominantly fast-twitch oxidative glycolytic (type IIa) fibers, had lower levels of expression, whereas ␥3 was undetectable in soleus muscle, which is a slow-twitch oxidative muscle with predominantly type I fibers. The type IIb fibers present predominantly in white muscles are abundant in fasttwitch myosin isoforms and have a more glycolytic metabolic phenotype. These fibers are recruited during high-intensity Fig. 5 . Effects of overexpressing ␥3S and ␥3L on specific AMPK␣ activity, AMPK␣ phosphorylation, AMPK␣ expression, glycogen content, glycogen synthase phosphorylation, and expression. TA muscles injected with Flagtagged AMPK␥3S-pCAGGS, AMPK␥3L-pCAGGS, or empty vector were processed as described previously. AMPK␣1 (A) and AMPK␣2 (B) activity and glycogen content (C) were measured as described in METHODS. To determine the phosphorylation of AMPK␣1 and AMPK␣2 separately, AMPK␣1 and AMPK␣2 were immunoprecipitated with anti-AMPK␣1 and AMPK␣2 antibody and then immunoblotted with an anti-phospho-AMPK␣ antibody. Protein expression level of AMPK␣1, AMPK␣2, and glycogen synthase and phosphorylation of glycogen synthase were detected by immunoblotting with specific antibodies. Results are means Ϯ SE, n ϭ 25, from 5 independent experiments. *P Ͻ 0.01 compared with control (one-way ANOVA).
types of contractions, rapidly providing energy through glycogenolysis. Whether wild-type ␥3 regulates AMPK activity in a manner that promotes the rapid utilization of glycogen is not known, but this is an interesting hypothesis to test in future studies. The lower levels of ␥3 expression in the red oxidative fibers provide an explanation for the previous observation that excess glycogen accumulation specifically occurs in white muscles in pigs with the RN Ϫ mutation in the PRKAG3 gene (R200Q mutation in AMPK␥3) (17) . Interestingly, incubation of muscles with the AMPK activator 5-aminoimidazole-4-carboxamide ribonucleoside (AICAR) only increases AMPK activity in the highly glycolytic white epitrochlearis muscle but has no effect in the red oxidative (type I) soleus muscle (1, 27) , (Hirshman MF, Goodyear LJ, and Hayashi T, unpublished observation). It is not known whether ␥3 expression is needed for AMPK to respond to AICAR in mouse skeletal muscle.
We successfully overexpressed AMPK␥3S and AMPK␥3L in mouse skeletal muscle by using a gene transfer and electroporation system and found that both splice variants associate with the endogenous AMPK␣ subunit (Fig. 4B ). Using this experimental system, we found that expression of AMPK␥3S and AMPK␥3L increased AMPK␣1 activity and phosphorylation but had no effect on AMPK␣2 activity and phosphorylation. The increase in AMPK␣1 activity was not due to an increase in AMPK␣1 protein, suggesting that the increase in phosphorylation of AMPK␣1 is responsible for the increase in AMPK␣1 activity. The mechanism by which ␥3 overexpression increases ␣1 phosphorylation and activity in vivo is unclear. Different ␥-subunits have been reported to account for different proportions of total AMPK activity (11), and therefore an exchange between isoforms could lead to a change in AMPK activity. However, endogenous ␥1 expression was not changed in response to ␥3 overexpression (Fig. 4A) , making this mechanism unlikely to account for the increase in AMPK␣1 activity. Another possibility is that ␥3 could favorably alter the conformation of ␣1-containing AMPK heterotrimer, which in turn could enhance ␣1 phosphorylation by upstream signals such as AMPK kinase or retard dephosphorylation by phosphatases. Unfortunately, we are not able to directly compare the amount of ␥3 subunit associated with ␣1 and ␣2, because anti-AMPK␣1 and anti-AMPK␣2 antibodies have different affinities to ␣1 and ␣2 subunits.
There are now multiple examples demonstrating ␣1-and ␣2-specific AMPK regulation in response to various perturbations (6, 27, 45) . One example is in cardiac hypertrophy, where AMPK␣1 activity and expression are increased whereas ␣2 expression is decreased (45) . Exercise training also specifically upregulates AMPK␣1 in skeletal muscle (6) . Another example is the recent report that obesity-related insulin resistance is associated with a specific impairment in contraction-stimulated ␣1 activity in skeletal muscle in rats (6). Because we found that ␥3 overexpression results in an ␣1-specific activation, in future studies it will be interesting to determine whether altered ␥3 expression plays a role in the impaired ␣1 response observed in these insulin resistant animals.
The AMPK␥3 mutation from arginine to glutamine at position 200 (R200Q) results in muscle glycogen accumulation in the Hampshire pig. In contrast, the valine-to-isoleucine mutation at position 199 in the same species reduces muscle glycogen content (3, 12) . The fact that adjacent mutations at V199 and R200 in the CBS domain of the ␥3 subunit cause opposite effects on muscle glycogen content suggests that structural changes in this part of the CBS domain alter enzyme function. In our study, modest overexpression of wild-type AMPK␥3 did not change muscle glycogen concentrations and had no effect on the expression and phosphorylation of glycogen synthase (Fig. 5C ), despite significant increases in AMPK␣1 activity. Furthermore, despite major differences in the amount of endogenous ␥3 protein among muscles of different fiber types, we did not observe a significant difference in muscle glycogen concentrations in these various muscles (Yu H, Hirshman MF, and Goodyear LJ, unpublished observation). These results suggest that wild-type AMPK␥3 does not directly regulate muscle glycogen concentrations and that the mutations are the cause of the alterations in glycogen metabolism.
In summary, we have cloned the full-length mouse AMPK␥3 gene and identified two ␥3 splice variants, ␥3S and ␥3L. Both ␥3S and ␥3L can associate with the ␣-and ␤-subunits of AMPK. These two splice variants appear to be differentially expressed in human and mouse skeletal muscle. Overexpression of either ␥3S or ␥3L results in a specific increase in AMPK␣1 activity and phosphorylation, but these changes are not associated with alterations in muscle glycogen.
